Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE) (Project HOPE)

February 4, 2026 updated by: VA Office of Research and Development

Virtual Hope Box Enhanced Facilitation in High-Risk Suicidal Veterans

This study will test whether a novel intervention, Virtual Hope Box Enhanced Facilitation (VHB-EF), reduces suicide risk in Veterans after discharge from inpatient psychiatric hospitalization. Additionally, this study will also conduct interviews with Veterans and healthcare providers to explore barriers and facilitators to future adoption of the VHB-EF intervention in healthcare settings.

Study Overview

Detailed Description

The specific aims of this study are:

Aim 1: To evaluate the effects of VHB-EF for reducing suicide behaviors (primary outcome).

H1: Suicidal Veterans in the VHB-EF arm will be less likely to have suicide behaviors over the 6 months following enrollment compared to those in the EUC condition. The investigators will also examine the effects of VHB-EF on severity of suicidal ideation (secondary outcome).

Aim 2: Examine intervention mechanisms by measuring the effects of VHB-EF on potential mediators, 1) reasons for living, and 2) self-efficacy to (a) cope and (b) refrain from suicide attempts.

H2: VHB-EF Veterans will report higher levels of reasons for living and self-efficacy, compared to EUC. Exploratory sub-aim: The investigators will test the hypothesis that higher levels of reasons for living and self-efficacy will partially mediate the effect of VHB-EF on suicide behaviors over 6-months. Furthermore, the investigators will measure the effects of VHB-EF (vs. EUC) on depressive symptoms and healthcare utilization, and their potential role as mediators of outcomes.

Aim 3: To examine the determinants (barriers and facilitators) of VHB-EF adoption to inform future implementation and sustainability of VHB-EF across the VA. The investigators will conduct qualitative interviews with providers and Veterans to determine the feasibility and acceptability of VHB-EF. This will be used to refine the intervention to maximize the impact of future implementation.

Methods: This is a 2-site randomized effectiveness-implementation hybrid type I trial that will recruit Veterans (N=928) hospitalized for suicidal crises, test this intervention, and gather data to support future implementation. Outcomes will be assessed at 6 weeks, 3 months, and 6 months post-baseline. The study will also include qualitative interviews with providers and Veterans to assess the feasibility and acceptability of VHB-EF.

Significance: This innovative study is the first to test the VHB's impact on suicidal behavior in Veterans during high-risk periods following acute care, addressing a key gap in suicide prevention for this vulnerable group.

Study Type

Interventional

Enrollment (Estimated)

928

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48105-2303
        • Recruiting
        • VA Ann Arbor Healthcare System, Ann Arbor, MI
        • Sub-Investigator:
          • Mark A. Ilgen, PhD
        • Contact:
        • Sub-Investigator:
          • Paul N Pfeiffer, MD MS
        • Principal Investigator:
          • Courtney L Bagge, PhD MA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Those enrolled in the RCT component of this study must be:

  • 1) Veterans aged 18 or older
  • 2) admitted to the inpatient psychiatric unit for a recent suicidal crisis
  • 3) medically stable (the patient's medical and psychological fitness [including aggression] to provide informed consent will be determined by a member of the patient's treatment team)
  • 4) A score of 3 or greater on the Callahan 6-item cognitive screening.
  • 5) report current suicidal ideation (Scale for Suicidal Ideation [SSI]; sum of items 4 and 5 > 0, referencing the week prior to their hospitalization) as reported during the screening interview
  • 6) no reported use of the VHB within the past 12-months
  • 7) access to a smartphone to download the VHB app

Exclusion Criteria:

Veterans will be found ineligible for the program if:

  • 1) do not understand English
  • 2) are prisoners
  • 3) are unable to provide informed consent
  • 4) have profound psychotic symptoms and/or cognitive deficits that would prevent patients from understanding the content of the intervention and/or assessments
  • 5) to not have access to a smartphone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Hope Box Enhanced Facilitation (VHB-EF)
The VHB-EF intervention has two phases: (1) The in-person inpatient phase involves a single, one-on-one, 60-minute session delivered by the study interventionist prior to hospital discharge. During this session, the interventionist will obtain access to the participant's personal phone and assist them in downloading the VHB app. The interventionist will provide education about the app and personalized behavioral practice for each component of the app. They will also address strategies to enhance app use. In addition, participants will review a list of Veteran mental health resources, community services, Veteran service organizations, and other Veteran social support services available to Veterans in the area. (2) The remote-delivery phase builds on the work begun in the hospital via 2 follow-up phone contacts within 14 days following discharge, during which the study interventionist will monitor risk, review/revise VHB content, and support app use and outpatient treatment engagement.
The VHB-EF intervention has two phases: (1) The in-person inpatient phase involves a single, one-on-one, 60-minute session delivered by the study interventionist prior to hospital discharge. During this session, the interventionist will obtain access to the participant's personal phone and assist them in downloading the VHB app. The interventionist will provide education about the app and personalized behavioral practice for each component of the app. They will also address strategies to enhance app use. In addition, participants will receive a list of Veteran mental health resources, community services, Veteran service organizations, and other Veteran social support services available to Veterans in the area. (2) The remote-delivery phase builds on the work begun in the hospital via 2 follow-up phone contacts within 14 days following discharge, during which the study interventionist will monitor risk, review/revise VHB content, and support app use and outpatient treatment engagement.
Other Names:
  • VHB-EF
Active Comparator: Enhanced Usual Care (EUC)
The EUC condition will involve a one-on-one, 30-minute session delivered by the study interventionist prior to hospital discharge, during which the interventionist will review Veteran mental health resources, community services, Veteran service organizations, and other Veteran social support services available to Veterans in the area. The EUC session will remain focused only on reviewing the standardized list of Veteran and community services; no counseling will be provided, and the list provided by the study interventionist does not include non-services (i.e., does not list any smartphone applications, including the VHB app).
The EUC condition will involve a one-on-one, 30-minute session delivered prior to hospital discharge, during which the study interventionist will review a list of Veteran mental health resources, community services, Veteran service organizations, and other Veteran social support services available to Veterans in the area. The EUC session will remain focused only on reviewing the standardized list of Veteran and community services; no counseling will be provided, and the list provided by the study interventionist does not include non-services (i.e., does not list any smartphone applications, including the VHB app).
Other Names:
  • EUC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 month Suicide Behaviors (measured by the Columbia Suicide Severity Rating Scale [C-SSRS])
Time Frame: 6 months
Suicide behaviors will be measured by the C-SSRS and will be administered as a semi-structured interview. The definition of suicide behaviors for the primary outcome will consist of any actual suicide attempt or interrupted suicide attempt or aborted suicide attempt during the specified time period.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 month Suicidal ideation (measured by the Scale for Suicidal Ideation [SSI]-Worst Point)
Time Frame: 6 months
Worst-point severity of suicidal ideation will be measured by the Scale for Suicidal Ideation (SSI) interview. The total score (sum of the first 19 items) will be used. Scores range from 0 to 38. Increasing scores reflect greater suicide risk.
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 week Self-efficacy to avoid suicidal action (measured by the Self-Efficacy to Avoid Suicidal Action [SEASA] scale)
Time Frame: 6 weeks
Participants' self-efficacy to avoid suicidal action will be measured by the Self-Efficacy to Avoid Suicidal Action (SEASA) scale. Each item is scored on a 0-9 scale from "very uncertain" to "very certain" to indicate level of confidence. Prior studies have found that lower scores on the SEASA are associated with a higher incidence and greater severity of suicide attempts.
6 weeks
6 week Ability to cope with stressful situations (measured by the Coping Self-Efficacy [CSE]-To Stop Unpleasant Emotions and Thoughts subscale)
Time Frame: 6 weeks
Participants' coping self-efficacy will be measured by the Coping Self-Efficacy (CSE) Stopping Unpleasant Emotions and Thoughts subscale. Respondents rate each item on a scale from 0 (cannot do at all) to 10 (certain can do). Scores range from 0 to 40. Higher scores represent greater coping self-efficacy.
6 weeks
6 week Reasons to live (measured by the Brief Reasons for Living Inventory [BRFL])
Time Frame: 6 weeks
The Brief Reasons for Living Inventory (BRFL) is a 12-item self-report measure in which the participant rates each item in terms of its importance to them (1 - not at all important; 6 - extremely important). Scores range from 12 to 72. Higher scores indicate greater reasons for living.
6 weeks
3 month Suicide attempts (measured by the Suicide Attempt and Self-Injury Count [SASSI-Count], actual attempt)
Time Frame: 3 months
Suicide attempts will be measured by the SASSI-Count and will be administered as a semi-structured interview. The definition of suicide attempt will consist of any actual suicide attempt during the specified time period.
3 months
3 month Suicide attempts (measured by the VA electronic medical record) actual or interrupted or aborted)
Time Frame: 3 months
Suicide attempts will be measured by documentation via the VA electronic medical record. The definition of suicide attempt will consist of any actual suicide attempt, interrupted, or aborted suicide attempt during the specified time period.
3 months
3 month Suicide attempts (measured by the Columbia Suicide Severity Rating Scale [C-SSRS], actual attempt)
Time Frame: 3 months
Suicide attempts will be measured by the C-SSRS and will be administered as a semi-structured interview. The definition of suicide attempt will consist of any actual suicide attempt during the specified time period.
3 months
3 month Suicidal ideation (measured by the Scale for Suicidal Ideation [SSI]-Current)
Time Frame: 3 months
Current severity of suicidal ideation will be measured by the Scale for Suicidal Ideation (SSI) interview. The total score (sum of the first 19 items) will be used. Scores range from 0 to 38. Increasing scores reflect greater suicide risk.
3 months
3 month Suicidal ideation (measured by the Scale for Suicidal Ideation [SSI]-Worst)
Time Frame: 3 months
Worst-point severity of suicidal ideation will be measured by the Scale for Suicidal Ideation (SSI) interview. The total score (sum of the first 19 items) will be used. Scores range from 0 to 38. Increasing scores reflect greater suicide risk.
3 months
3 month Self-efficacy to avoid suicidal action (measured by the Self-Efficacy to Avoid Suicidal Action [SEASA] scale)
Time Frame: 3 months
Participants' self-efficacy to avoid suicidal action will be measured by the Self-Efficacy to Avoid Suicidal Action (SEASA) scale. Each item is scored on a 0-9 scale from "very uncertain" to "very certain" to indicate level of confidence. Prior studies have found that lower scores on the SEASA are associated with a higher incidence and greater severity of suicide attempts.
3 months
3 month Ability to cope with stressful situations (measured by the Coping Self-Efficacy [CSE]-To Stop Unpleasant Emotions and Thoughts subscale)
Time Frame: 3 months
Participants' coping self-efficacy will be measured by the Coping Self-Efficacy (CSE) Stopping Unpleasant Emotions and Thoughts subscale. Respondents rate each item on a scale from 0 (cannot do at all) to 10 (certain can do). Scores range from 0 to 40. Higher scores represent greater coping self-efficacy.
3 months
3 month Suicide attempts (measured by the Columbia Suicide Severity Rating Scale [C-SSRS], actual or interupted)
Time Frame: 3 months
Suicide attempts will be measured by the C-SSRS and will be administered as a semi-structured interview. The definition of suicide attempt will consist of any actual suicide attempt or interrupted suicide attempt during the specified time period.
3 months
3 month Reasons to live (measured by the Brief Reasons for Living Inventory [BRFL])
Time Frame: 3 months
The Brief Reasons for Living Inventory (BRFL) is a 12-item self-report measure in which the participant rates each item in terms of its importance to them (1 - not at all important; 6 - extremely important). Scores range from 12 to 72. Higher scores indicate greater reasons for living.
3 months
3 month Suicide attempts (measured by the Columbia Suicide Severity Rating Scale [C-SSRS], actual or interrupted or aborted)
Time Frame: 3 months
Suicide attempts will be measured by the C-SSRS and will be administered as a semi-structured interview. The definition of suicide attempt will consist of any actual suicide attempt, interrupted, or aborted suicide attempt during the specified time period.
3 months
6 week Virtual Hope Box (VHB) use frequency
Time Frame: 6 weeks
Participants will self-report the frequency of their VHB mental health app usage using the Smartphone App Questionnaire, which ranges from 0(never) to 7 (every day). Higher scores indicate higher usage.
6 weeks
6 week VHB app usage Timeline Follow-Back (TLFB)
Time Frame: 6 weeks
Participants will report the days that they used the VHB app during the specified time period. A TLFB procedure will be used. Possible ranges include 0=never to # of possible days in the 6 week assessment.
6 weeks
Inpatient Phase-VHB app beliefs, usage, and treatment satisfaction
Time Frame: baseline
The VHB-EF treatment group will complete a brief self-report questionnaire during the inpatient treatment session. This will ask pre-post session questions regarding their use of the VHB app. It also asks questions regarding participant satisfaction. This measure was created by the investigative team.
baseline
Remote Phase-VHB app usage
Time Frame: 10 days post-discharge weeks
The VHB-EF treatment group will complete a brief self-report questionnaire regarding their use of the VHB app during the remote phase of the intervention. This measure was created by the investigative team.
10 days post-discharge weeks
6 week Depression symptoms (measured by the Patient Health Questionnaire [PHQ-9])
Time Frame: 6 weeks
The Patient Health Questionnaire (PHQ-9) is a self-report measure where higher scores represent greater symptoms of depression. Scores range from 0 to 27.
6 weeks
3 month Depression symptoms (measured by the Patient Health Questionnaire [PHQ-9])
Time Frame: 3 months
The Patient Health Questionnaire (PHQ-9) is a self-report measure where higher scores represent greater symptoms of depression. Scores range from 0 to 27.
3 months
6 week Self-reported utilization of health care services
Time Frame: 6 weeks
Self-reported health services used will be assessed by an adapted version of the Health Services Inventory
6 weeks
3 month Self-reported utilization of health care services
Time Frame: 3 months
Self-reported health services used will be assessed by an adapted version of the Health Services Inventory.
3 months
6 week VA medical record attendance in outpatient mental health treatment
Time Frame: 6 weeks
Attendance in outpatient mental health treatment will be assessed by the VA medical record.
6 weeks
3 month VA medical record attendance in outpatient mental health treatment
Time Frame: 3 months
Attendance in outpatient mental health treatment will be assessed by the VA medical record.
3 months
Baseline demographics
Time Frame: Baseline
We will use the demographic measure within the PhenX Tool Kit to measure participants' age, gender, race, ethnicity, marital status, education, and annual family income
Baseline
Baseline Alcohol misuse (measured by the Alcohol Use Identification Test [AUDIT])
Time Frame: baseline
The AUDIT is a self-report measure that assesses alcohol intake and potential abuse. Scores greater to or equal to 8 indicate problematic alcohol use.
baseline
Baseline Drug use (measured by the Drug Abuse Screening Test [DAST-10])
Time Frame: baseline
DAST-10 is a screening tool consisting of 10 Yes/No questions that assess drug use problems. Potential scores range from 0 to 10. Higher scores represent greater problematic use.
baseline
Baseline Anxiety (measured by the Generalized Anxiety Disorder 7 [GAD-7])
Time Frame: baseline
The GAD-7 is a 7-item self-report measure that assesses generalized anxiety symptoms. Scores range from 0 to 21. Higher scores represent greater anxiety.
baseline
6 week Coping strategies
Time Frame: 6 weeks
Presence of self-reported coping strategies used will be assessed by an adapted version of the Brief Cope.
6 weeks
3 month Virtual Hope Box (VHB) use frequency
Time Frame: 3 months
Participants will self-report the frequency of their VHB mental health app usage using the Smartphone App Questionnaire, which ranges from 0(never) to 7 (every day). Higher scores indicate higher usage.
3 months
3 month Coping strategies
Time Frame: 3 months
Presence of self-reported coping strategies used will be assessed by an adapted version of the Brief Cope.
3 months
3 month VHB app usage Timeline Follow-Back (TLFB)
Time Frame: 3 months
Participants will report the days that they used the VHB app during the specified time period. A TLFB procedure will be used. Possible ranges include 0=never to # of possible days in the assessment.
3 months
6 week Suicide attempts (measured by the Columbia Suicide Severity Rating Scale [C-SSRS], actual or interrupted)
Time Frame: 6 week
Suicide attempts will be measured by the C-SSRS and will be administered as a semi-structured interview. The definition of suicide attempt for the primary outcome will consist of any actual suicide attempt or interrupted suicide attempt during the specified time period.
6 week
6 weeks Suicide attempts (measured by the Columbia Suicide Severity Rating Scale [C-SSRS] actual attempt)
Time Frame: 6 week
Suicide attempts will be measured by the C-SSRS and will be administered as a semi-structured interview. The definition of suicide attempt f will consist of any actual suicide attempt during the specified time period.
6 week
6 week Suicide attempts (measured by the Columbia Suicide Severity Rating Scale [C-SSRS] actual, interrupted, or aborted)
Time Frame: 6 weeks
Suicide attempts will be measured by the C-SSRS and will be administered as a semi-structured interview. The definition of suicide attempt will consist of any actual suicide attempt, interrupted, or aborted suicide attempt during the specified time period.
6 weeks
6 week Suicide attempts (measured by the Suicide Attempt and Self-Injury Count [SASSI-Count], actual attempt)
Time Frame: 6 weeks
Suicide attempts will be measured by the SASSI-Count and will be administered as a semi-structured interview. The definition of suicide attempt will consist of any actual suicide attempt during the specified time period.
6 weeks
6 week Suicide attempts (measured by the VA electronic medical record) actual or interrupted or aborted attempt)
Time Frame: 6 weeks
Suicide attempts will be measured by documentation via the VA electronic medical record. The definition of suicide attempt will consist of any actual suicide attempt, interrupted, or aborted suicide attempt during the specified time period.
6 weeks
6 week Suicidal ideation (measured by the Scale for Suicidal Ideation [SSI]-Current)
Time Frame: 6 week
Current severity of suicidal ideation will be measured by the Scale for Suicidal Ideation (SSI) interview. The total score (sum of the first 19 items) will be used. Scores range from 0 to 38. Increasing scores reflect greater suicide risk.
6 week
6 week Suicidal ideation (measured by the Scale for Suicidal Ideation [SSI]-Worst)
Time Frame: 6 weeks
Worst-point severity of suicidal ideation will be measured by the Scale for Suicidal Ideation (SSI) interview. The total score (sum of the first 19 items) will be used. Scores range from 0 to 38. Increasing scores reflect greater suicide risk.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Courtney L Bagge, PhD MA, VA Ann Arbor Healthcare System, Ann Arbor, MI

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 26, 2025

Primary Completion (Estimated)

November 30, 2028

Study Completion (Estimated)

May 31, 2029

Study Registration Dates

First Submitted

April 15, 2024

First Submitted That Met QC Criteria

April 17, 2024

First Posted (Actual)

April 22, 2024

Study Record Updates

Last Update Posted (Actual)

February 9, 2026

Last Update Submitted That Met QC Criteria

February 4, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide Attempt

Clinical Trials on Virtual Hope Box Enhanced Facilitation

Subscribe